• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
TechNeuralink

A major medical ethics group just asked the FDA to disqualify data from Elon Musk’s Neuralink animal experiments: ‘We want the FDA to proactively launch an investigation’

Prarthana Prakash
By
Prarthana Prakash
Prarthana Prakash
Europe Business News Reporter
Down Arrow Button Icon
Prarthana Prakash
By
Prarthana Prakash
Prarthana Prakash
Europe Business News Reporter
Down Arrow Button Icon
December 13, 2022, 2:56 PM ET
Elon Musk
In November, Elon Musk said that implants on human brains were roughly six months away.CARINA JOHANSEN—NTB/AFP/Getty Images

Elon Musk has several different businesses, from making electric cars at Tesla to building rocket ships at SpaceX. But one of his lesser-known businesses has been in the spotlight lately over accusations that it needlessly killed about 1,500 animals. 

Neuralink, Musk’s brain technology startup, has come under fire recently for its animal testing practices, and the company is being investigated for violations of animal welfare. Over 20 current and former employees claim that the tests were being conducted hastily, and that workers were under pressure from Musk to expedite trials, leading to botched experiments and excessive animal deaths.   

Now, a major medical ethics advocacy group, the Physicians Committee for Responsible Medicine, has requested the Food and Drug Administration hold Neuralink accountable for violating protocols on biological tests, and disqualify the data obtained from animal testing, the Washington Post reported Tuesday. It has also asked the FDA to ban additional animal tests by Neuralink.

“Between what we’ve seen in public records and what has been reported, it’s hard to imagine that Neuralink’s animal experiments meet FDA’s requirements,” Deborah Dubow Press, associate general counsel with the Physicians Committee, said in a statement.

In an interview with Fortune, Ryan Merkley, director of research advocacy for the organization, said that it was concerned that the documents Neuralink was providing to the FDA were not “trustworthy.”

“We want FDA to take a very close look at whatever Neuralink is providing, and ideally, we want the FDA to proactively launch an investigation because it’s clear that over the years from public records and whistleblower reports that Neuralink has not followed its own internal protocols.”

Neuralink did not reply to Fortune’s request for comment.

If the FDA does dismiss the results collected thus far, it could threaten Neuralink’s business plans for its brain implants and the company’s stated vision of creating a “brain-computer interface.” At a Neuralink event in November, Musk said that implants on human brains were roughly six months away and that the company had already submitted its request to the FDA. He presented a video of a monkey named Pager playing “monkey mind pong,” which resembles ping-pong but he plays it in his mind. Musk claimed that Pager would not be able to do so without using a brain implant, which he described as “replacing a piece of the skull with a smartwatch.”

“Before we would even think of putting a device in an animal, we do everything we possibly can with rigorous benchtop testing, so we are not cavalier,” Musk said during the presentation. He also said that whenever a device was implanted into a sheep, pig, or monkey, it was done to confirm their testing results rather than to explore the outcomes of the experiment on the animal.

The Physicians Committee for Responsible Medicine based its request to the FDA on 700 pages’ worth of documents that were obtained after suing the California National Primate Research Center at the University of California–Davis, which was tasked with conducting the Neuralink animal experiments. The tests were conducted on rhesus macaques, a pink-faced species of monkey originating in Asia, the Washington Post reported.  

Our new weekly Impact Report newsletter examines how ESG news and trends are shaping the roles and responsibilities of today's executives. Subscribe here.

About the Author
Prarthana Prakash
By Prarthana PrakashEurope Business News Reporter
LinkedIn icon

Prarthana Prakash was a Europe business reporter at Fortune.

See full bioRight Arrow Button Icon

Latest in Tech

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Tech

NewslettersFortune Tech
AI plot twist: Why did OpenAI kill its Sora video star?
By Alexei OreskovicMarch 25, 2026
1 hour ago
MagazineSoftware
Wall Street is convinced AI will kill SaaS. History and economics say something else
By Jeremy KahnMarch 25, 2026
3 hours ago
AsiaChina
China could be the ‘big winner’ in the AI race, thanks to abundant power, cheap manufacturing, and an open-source craze
By Nicholas GordonMarch 25, 2026
4 hours ago
Magazinechief executive officer (CEO)
The AI era has a message for every CEO: Adapt or die
By Beatrice NolanMarch 25, 2026
4 hours ago
Origin cofounders Chris Bruce (left) and Pete Craghill.
Startups & VentureVenture Capital
Exclusive: AI-powered benefits platform Origin raises $30 million in fresh funding to bring CHROs visibility into benefits usage and spend
By Jeremy KahnMarch 25, 2026
4 hours ago
Man with glasses wearing a black collared shirt
LawDonald Trump
‘Attempted corporate murder’: Judge calls on Anthropic and Department of War to explain dispute over supply chain risk 
By Amanda GerutMarch 24, 2026
10 hours ago

Most Popular

Commentary
The Treasury just declared the U.S. insolvent. The media missed it
By Fortune EditorsMarch 23, 2026
2 days ago
Magazine
The youngest-ever female CEO of a Fortune 500 company is fighting Trump's cuts to keep Medicaid strong
By Fortune EditorsMarch 24, 2026
1 day ago
Economy
It took 200 years for national debt to hit $1 trillion. Annual interest alone now exceeds that—a 'crushing legacy we must reverse,' says budget chair
By Fortune EditorsMarch 23, 2026
2 days ago
Energy
Nobel laureate Paul Krugman calls it 'treason': $580 million in suspicious oil futures traded minutes before Trump's Iran reversal
By Fortune EditorsMarch 24, 2026
17 hours ago
Success
Palantir’s billionaire CEO says only two kinds of people will succeed in the AI era: trade workers — ‘or you’re neurodivergent’
By Fortune EditorsMarch 24, 2026
20 hours ago
Personal Finance
Current price of oil as of March 24, 2026
By Fortune EditorsMarch 24, 2026
23 hours ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.